XML 29 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Dividends Paid Previously or Declared
The following table presents the cash dividends either paid previously or declared by our board of directors for future payment on a per share basis during 2026 and 2025:
20262025
First quarter$0.240 $0.215 
Second quarter0.240 0.220 
Third quarter0.220 
Fourth quarter0.220 
Total$0.480 $0.875 
Stock Options Granted
The following tables summarize the details of options granted under our stock option plans that were outstanding as of March 31, 2026, and the assumptions used to value those grants. All such grants were effective at the close of business on the grant date.
 Options
Granted
Option Exercise
Price
Closing Stock Price on Grant DateMarch 31, 2026
Grant DateOptions
Outstanding
Options
Exercisable
January 2, 20261,508,081 $41.00 $40.440 1,502,232 169,011 
January 2, 20251,366,636 $36.00 $35.555 1,257,104 283,416 
January 2, 20241,629,824 $32.00 $31.775 1,358,624 507,886 
January 3, 20232,143,886 $24.00 $23.700 1,494,697 755,845 
January 3, 20221,426,876 $31.00 $30.990 896,097 616,481 
January 4, 20211,483,020 $24.00 $23.825 783,876 666,394 
January 2, 20201,804,526 $19.00 $18.615 757,796 654,340 
January 2, 20192,633,848 $13.00 $12.853 612,620 541,648 
January 2, 20182,175,872 $13.75 $13.635 298,421 298,421 
January 3, 20173,059,156 $11.75 $11.738 135,509 135,509 
Total19,231,725 9,096,976 4,628,951 
Fair Value Assumptions for Options Granted
Grant DateRisk-free
Interest Rate
Expected Life
of Option in
Years
Expected
Dividend
Yield
Expected
Stock
Volatility
Estimated Fair
Value of Stock
Option
January 2, 20263.7%5.002.2%23.79%$8.52 
January 2, 20254.3%5.002.2%27.36%$8.86 
January 2, 20243.8%5.002.2%28.44%$7.94 
January 3, 20234.0%5.002.6%29.58%$5.81 
January 3, 20221.3%5.001.7%28.52%$6.84 
January 4, 20210.4%5.002.0%29.17%$4.79 
January 2, 20201.7%5.002.4%25.70%$3.41 
January 2, 20192.5%5.002.9%23.96%$2.20 
January 2, 20182.2%5.002.3%23.45%$2.51 
January 3, 20171.9%5.002.6 %24.49 %$2.10 
Reconciliation of Denominators Used in Computation of Basic and Diluted Net Income Per Share
The following tables present a reconciliation of the denominators used in the computation of basic and diluted net income per share and a summary of the options to purchase shares of common stock which were excluded from the diluted net income per share calculation because they were anti-dilutive:
 Three-month Period
Reconciliation20262025
Basic weighted average shares outstanding1,148,159,704 1,146,935,722 
Weighted shares assumed upon exercise of stock options2,740,697 2,576,501 
Diluted weighted average shares outstanding1,150,900,401 1,149,512,223 
Anti-Dilutive Options Excluded
 Three-month Period
Summary of Anti-dilutive Options Excluded20262025
Options to purchase shares of common stock1,318,407 2,617,668 
Weighted average exercise prices of options$41.00 33.89